Gridiron Equities

1.6K posts

Gridiron Equities

Gridiron Equities

@GridironEq

Family office with a passion for biotechnology, drug development and medical technology. Tweets are opinions, not recommendations. #CantClickTheMouseForYou

Manhattan, NY Katılım Nisan 2018
73 Takip Edilen805 Takipçiler
Gridiron Equities
Gridiron Equities@GridironEq·
$TMDX PT lowered to $124 from $152 at Canaccord.
English
0
0
2
446
Gridiron Equities
Gridiron Equities@GridironEq·
Respected analyst Matt O’Brien lowers PT to $120 on $TMDX. He cites investors should take advantage of pullback.
Gridiron Equities tweet media
English
0
6
19
2.8K
Gridiron Equities retweetledi
Will
Will@medtechmd·
Despite the dilution and $9.00 gift to the institutions, $MGTX price target to $24.00.
Will tweet media
English
0
1
3
304
Gridiron Equities retweetledi
Will
Will@medtechmd·
This analyst has been a skeptic of $TMDX and it’s role in revolutionizing the organ transplant paradigm. Always late to the game in his analysis, he now jumps in.
Will tweet media
English
0
8
54
4.2K
Gridiron Equities
Gridiron Equities@GridironEq·
Piper Sandler raises PT on $TMDX from $105 to $125.
Gridiron Equities tweet media
English
0
2
33
4.1K
Gridiron Equities retweetledi
Oliver | MMMT Wealth (CPA)
Oliver | MMMT Wealth (CPA)@MMMTwealth·
$TMDX CRUSHED IT. Even higher than my estimates 🔥 Sales $144M vs Est. $123M✅ EPS $0.70 vs Est. $0.24✅ FY25 Guidance Sales $575M vs Est. $541M✅
Oliver | MMMT Wealth (CPA) tweet media
English
9
26
191
16.7K
Gridiron Equities retweetledi
Will
Will@medtechmd·
Slide From ISHLT Presentation This Morning: DCD Heart Transplantation In North America On The Rise. This Is The Domain OF $TMDX OCS NOP. No Other Platform Can Compete W/ TransMedics Air Or NOP.
Will tweet media
English
3
7
42
6.8K
Gridiron Equities
Gridiron Equities@GridironEq·
@LoRezTrader @smallmidcaps They are creating another facility to produce the raw materials for the OCS, thus diversifying their production, which is smart. Do not expect them to create an NOP program ex-US anytime soon. The next gen OCS and kidney are the near to medium term drivers of revenue growth.
English
0
1
4
202
LoRezTrader
LoRezTrader@LoRezTrader·
@smallmidcaps @GridironEq I'm not sure if they plan to have as robust an NOP/logisitics network as they do here in the U.S. - unless that has changed, at least? Waleed has commented on it in the past. So it may not be equivalent overseas, or at least not initially?
English
1
0
1
162
Gridiron Equities
Gridiron Equities@GridironEq·
$TMDX expanding outside the United States. Likely means they are bullish on expansion of ex-US and are diversifying manufacturing production locations. Bullish signal.
Natan@nataninvesting

$TMDX is opening its first manufacturing site outside the US in Mirandola, Italy, investing 30M. The company plans to hire over 50 highly skilled professionals. This makes me very confident in holding a quite large position (12%) despite the short-seller report.

English
3
8
57
14.3K
lucidjp
lucidjp@lucidjp·
@GridironEq There’s twice as many ppl in Europe vs the U.S. this is good news
English
1
0
0
91
Gridiron Equities
Gridiron Equities@GridironEq·
Top surgeons in the field set the record straight $HUMA
Gridiron Equities tweet mediaGridiron Equities tweet mediaGridiron Equities tweet media
English
3
11
48
18K
Gridiron Equities
Gridiron Equities@GridironEq·
$HUMA rollout off to a good start. Here’s why: There are 200 Level I trauma centers in the United States to target. 🎯 34 hospitals have already initiated the approval process to purchase. • That is 17% of Level 1 trauma centers!
Gridiron Equities@GridironEq

$HUMA: “So far the market has responded well, and 34 hospitals have already initiated the (VAC) approval process. We are also excited that just 16 days after having the commercial inventory availability, we made our first shipments of Symvess”.

English
1
2
12
1.1K